Craig Gulliford
CEO @ Creo Medical
Craig Gulliford is a seed investor at Creo Medical focused on Health Care and Medical Device. Craig qualified with an MSc in Electronic Engineering from the University College of North Wales and has significant experience in building businesses from early stage through to significant scale.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 60%
Last updated:
For AI agents: llms.txt
Industries Craig Gulliford invests in
Stages Craig Gulliford invests in
Countries Craig Gulliford invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 2 (40%)
- Medical Device 2 (40%)
- Fitness 1 (20%)
- Medical 1 (20%)
- Wellness 1 (20%)
Stage
- Seed 2 (40%)
- Series A 1 (20%)
- Funding Round 1 (20%)
- Post-IPO Equity 1 (20%)
Country
- United Kingdom 2 (40%)
- United States 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
IQ Endoscopes
|
IQ Endoscopes is a range of single-use flexible endoscopes that provides images of the full length of the gut, helping in diagnostics and therapeutic procedures. | $5.4M / Series A / Oct 04, 2021 | |
|
IQ Endoscopes
|
IQ Endoscopes is a range of single-use flexible endoscopes that provides images of the full length of the gut, helping in diagnostics and therapeutic procedures. | $2M / Dec 22, 2020 | |
|
IQ Endoscopes
|
IQ Endoscopes is a range of single-use flexible endoscopes that provides images of the full length of the gut, helping in diagnostics and therapeutic procedures. | $2M / Seed / Dec 22, 2020 | |
Forth
|
Forth are a group of clinical and digital experts who are passionate about healthcare. They’re part of a new breed of digital healthcare companies who are transforming people’s relationship with their health by using technology to give them more information and help them gain greater control. | Seed / Feb 08, 2019 | |
Creo Medical
|
Creo Medical a medical device manufacturer based in Chepstow, South Wales. Founded in 2003, (formerly MicroOncology Ltd) we develop, manufacture and commercialise clinically innovative medical device technologies.They operate out of our new headquarters in Chepstow, South Wales where a controlled manufacturing area (including a Class 6Cleanroom) and creative R&D area have been installed. | $7.4M / Post-IPO Equity |
Co-Investors
About Creo Medical
Creo Medical a medical device manufacturer based in Chepstow, South Wales. Founded in 2003, (formerly MicroOncology Ltd) we develop, manufacture and commercialise clinically innovative medical device technologies.They operate out of our new headquarters in Chepstow, South Wales where a controlled manufacturing area (including a Class 6Cleanroom) and creative R&D area have been installed.
Creo Medical Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Charles Spicer
Chairman
|
|||
Chris Hancock
CTO & Founder
|
|||
|
Craig Gulliford
CEO
|
|||
Luis Ignacio Collantes
President EMEA
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Craig Gulliford invest in?
Craig Gulliford invests primarily in Health Care, Medical Device and Fitness startups, most often at Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Craig Gulliford?
Public channels for Craig Gulliford include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Craig Gulliford last invest?
The most recent investment recorded for Craig Gulliford closed in Oct 2021. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
